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Abstract
The use of cell culture models is a principal and fundamental technology used in understanding how mammalian cells work.
However, for some cell types such as mammary epithelia, the lines selected for extended culture are often transformed or
have chromosomal abnormalities, while primary cultures have such a curtailed lifespan that their use is restricted. For
example, mammary luminal epithelial cells (MECs) are used to study mechanisms of breast cancer, but the proliferation of
primary cell cultures is highly limited. Here we describe the establishment of a new culture system to allow extended
analysis of cultures of primary mouse MECs. In 2D monolayer culture, primary MECs showed a burst of proliferation 2–3 days
post isolation, after which cell cycle decreased substantially. Addition of mammary epithelial growth factors, such as
Epidermal Growth Factor, Fibroblast Growth Factor-2, Hepatocyte Growth Factor, and Receptor Activator for Nuclear Factor
kB Ligand, or extracellular matrix proteins did not maintain their proliferation potential, neither did replating the cells to
increase the mitogenic response. However, culturing MECs directly after tissue extraction in a 3D microenvironment
consisting of basement membrane proteins, extended the time in culture in which the cells could proliferate. Our data
reveal that the cellular microenvironment has profound effects on the proliferative properties of the mammary epithelia and
is dominant over growth factors. Moreover, manipulating the cellular environment using this novel method can maintain
the proliferative potential of primary MECs, thus enabling cell cycle to be studied as an endpoint after gene transfer or gene
deletion experiments.
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Introduction
Understanding the mechanisms of cell cycle regulation in
normal breast epithelia is essential for deciphering the defects of
breast cancer, and therefore for developing new therapies to treat
the disease. We have discovered, using molecular genetic
approaches, that the b1-integrin gene is necessary for the
proliferation of normal luminal epithelial cells within the breast
[1,2]. Gene deletion studies have also shown that b1-integrin is
required for breast cancer progression [3,4]. Thus the factors
controlling cell cycle regulation in breast epithelia are broader
than locally acting and systemic growth factors and hormones.
Luminal epithelial cells are the precursors of most breast cancers
and it is therefore important to determine the mechanisms linking
integrins with proliferative responses in this cell type. However,
this poses logistical issues because of the problems associated with
growing luminal cells in tissue culture.
Mammary epithelial cells (MECs) are widely used to study
epithelial cells in general, as well as mammary specific functions
such lactation. Although much work has been done using
immortalised cell lines, primary luminal MECs isolated directly
from the mouse or human mammary gland are a preferred model
because their phenotype is more similar to cells in vivo [5,6],
without the numerous changes associated with immortalisation
that can affect cell behaviour [7,8]. Indeed, studying mecha-
nisms of mammary development and function, such as ductal
morphogenesis and alveolar differentiation, are now possible with
the use of 3D culture techniques using reconstituted basement
membrane such as 3D BM-matrix [9,10].
Unfortunately, normal primary mammary epithelial cells
(MECs) have a poor growth response to conventional 2D culture
conditions, proliferating slowly, and undergoing apoptosis [11] or
becoming senescent [12]. While human MECs can be propagated
for a limited number of times, mouse MECs behave differently
and do not proliferate well after the first passage. Occasionally cells
can emerge from senescence through immortalisation, where
changes in genomic structure including telomere rescue occur
[13]. However, immortalisation disrupts the normal cell cycle
regulatory mechanisms, such as phosphorylation of Rb protein,
limiting the appropriateness of using immortalised lines for
studying cell cycle mechanisms. Moreover, MEC lines established
from mice often form hyperplasias when injected into mammary
fat pads [14]. Thus it is pressing to uncover ways of extending the
experimentally useful proliferation window in normal primary
MEC cell cultures.
In this paper, we have explored growth factor and extracellular
matrix (ECM) requirements for maximising the time frame of
luminal MEC proliferation in culture. For most of the experiments
herein, we have used luminal cells isolated from pregnant mouse
mammary glands, firstly because this is the time in development
when maximal proliferation in vivo occurs, and secondly because
cancers largely arise within the alveolar lobules rather than within
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e18144Cellular Environment and Mammary Proliferation
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e18144ducts themselves [15]. We find that manipulating the cellular
microenvironment alters the ability of such cells to undergo cell
cycle. This provides both new understanding of cell cycle
regulation in breast, and a practical solution for determining gene
function in this process.
Results
S-phase cell cycle progression in primary mouse
mammary epithelial cells in conventional 2D culture
Cell cycle studies have traditionally been conducted on
conventional 2D substrata. Therefore we initially examined the
proportion of MECs in S-phase that were isolated from pregnant
mouse mammary gland (P16–P18) and cultured on collagen I-
coated dishes (Fig. 1a). Throughout these studies, we used primary
cultures of normal non-immortalised MECs, studied directly after
isolation or after one passage [16]; we assessed S-phase cell cycle
progression in proliferating cells by 5-ethynyl-29-deoxyuridine
(EdU) incorporation into DNA, followed by detection with
fluorescent azide [17].
Approximately 40% of the cells were in S-phase 2–3 days
following isolation, but this fell to less than 10% cycling cells for
the remaining time of analysis. Both luminal and myoepithelial
cells are isolated during the preparation of MECs (which are
largely free of fibroblasts and endothelial cells). The proportion of
myoepithelial cells were quantified by counting the number of cells
positive for the myoepithelial cell marker, keratin 5, and was found
to be no more than 5–7% [16].
Similar cell cycle characteristics were also seen in MECs isolated
at different stages of pregnancy and development (Fig. 1b). The
profile was not significantly different in MECs isolated at
pregnancy days P12–14 with those from P16–18, and cells from
virgin mammary glands showed maximal cell cycle progression at
day 3 of culture, thereafter decreasing and remaining low from 5
days of culture (light grey bars).
Although the differences in proliferation between MECs from
ducts and alveoli were non-significant at the different time points,
in each case levels of proliferation $20% were only seen for the
first 2–4 d of culture, after which the percentage of cells in S-
phase fell to #10% for as long as the cells survived in standard
planar culture (Fig. 1b). We previously showed that after 4 d in
culture, luminal MECs begin to undergo substantial apoptosis
[11].
Growth factors or different ECM proteins cannot extend
or enhance the percentage of proliferating primary MECs
in 2D culture
Mechanisms of cell cycle are usually studied in cell lines in
which cells have undergone phenotypic, and sometimes genetic,
changes to promote extended lifespan. We wished to determine
methods that could reveal how the cell cycle is regulated in non-
immortalised, very early MEC cultures, and therefore examined
ways of extending this brief window of proliferation that
characterised the first 3–5 days of primary cell culture, using cells
from pregnant mammary glands.
A key cell cycle determinant of breast epithelia is growth factors.
Despite previous studies indicating that EGF and insulin are
sufficient for the growth of normal MECs [18], these factors
together with serum were not able to maintain more than 15%
cells in S-phase after day-4 of culture (Fig 1a). Moreover, adding
fresh growth factors did not reactivate cell cycle. In the mammary
gland in vivo, the growth factors that stimulate proliferation during
puberty and pregnancy include IGFs (whose action is mimicked by
high levels of insulin in our cultures), Amphiregulin (whose effects
are mediated by EGF in culture), Fibroblast Growth Factor-2
(basic FGF) [19], Receptor Activator for Nuclear Factor k B
Ligand (RANKL) [20,21] and Wnt [22]. To determine if these
factors promote cell cycle in MECs, cells were cultured using
amounts of bFGF, RANKL, or Wnt3a known to have a
physiological effect (Fig. 2a). None of the growth factors showed
any significant effect on the percentage of cells in S-phase
compared to control cells.
In addition to growth factors, ECM proteins can alter the
proliferative response of luminal MECs [23]. MECs were cultured
on different ECM proteins and proliferation was assessed 4 d after
plating cells on collagen I, laminin I, vitronectin, fibronectin or
directly on the plastic of the culture dish (Fig. 2b). The proportion
of proliferating cells on collagen I was approximately 8% (i.e. as in
Fig. 1a and Fig. 2ai), but less than 5% on the other substrata.
Thus, the proliferation potential of MECs cannot be extended
or enhanced by manipulating the culture medium by addition of
growth factors, or by altering the 2D ECM protein substratum.
Replating does not restore the proliferation potential of
primary MECs in 2D culture
Contact inhibition and spatial restriction are negative regulators
of epithelial cell cycle. During cell-cell contact, the ligation of E-
cadherin up-regulates the cell cycle inhibitor p27, blocking
proliferation [24]. Since MECs on collagen I were nearly
confluent at day 4 when the proliferation levels were very low
(Fig. 1a) we reasoned that releasing contact inhibition by replating
the cells might reactivate cell cycle. MECs were replated at a
density of approximately 2.5610
4 cells per cm
2, either when the
peak of cells were in S-phase, i.e. ,45% at 2-days after isolation,
or once proliferation had decreased, i.e. ,10%, after 4 days.
Proliferation was analysed each day for 4 days following replating,
but at no point were more than 6% of cells in S-phase (Fig. 3a).
Replating onto different ECM also did not promote prolifer-
ation (Fig. 3b); similarly the addition of HGF [25] (not shown),
bFGF, RANKL, or Wnt3a to complete media either alone or in
combination, to replated cells failed to promote proliferation
(Fig. 3c). MECs harvested from different pregnancy time points
also failed to proliferate following replating (Fig. 3d).
These results show that monolayer cultured MECs do not cease
proliferating because they become confluent, but rather they enter
an apparently irreversible quiescence. In contrast to cell lines, this
quiescence cannot be rescued by trypsinising and replating the
cells and appears to be irreversible under 2D growth conditions.
Moreover, the cells do not undergo senescence, as judged by b-gal
staining (data not shown).
Figure 1. Primary MECs display limited proliferation potential in 2D culture. (a) MECs were isolated from pregnant mice and plated onto
collagen I coated coverslips in complete media. (i) The percentage of proliferating cells was determined by EdU incorporation on each day for 6-d
after isolation. Statistical significance determined by ANOVA is indicated: ***=p,0.001. (ii) Cells were co-stained with keratin 5 to detect the
myoepithelial cells. Scale bar: 13 mm. (b) MECs from pregnancy days 12–14 (mid-grey) and 10 week old virgin (light-grey) mice were isolated and
treated as above, and their proliferation compared to the cells isolated at pregnancy days 16–18 (black) by EdU incorporation. There were no
significant differences in proliferation between MECs from ducts and alveoli within each time point (not shown on the graph).
doi:10.1371/journal.pone.0018144.g001
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proliferation potential of primary MECs
3D ECMs such as a BM-matrix have been used extensively to
the study cell behaviour because they bestow an environment
more similar to that found in vivo than planar dishes [26,27,28].
Consequently, we explored whether 3D culture might provide an
opportunity to maintain or extend the proliferation potential of
primary cultures. P16–18 MECs form spherical acini when they
are cultured in 3D BM-matrix (Fig. 4a). The proliferation rate of
primary cells from late pregnancy in these 3D structures over the
course of 7 days had a similar profile to that cultured in 2D, with
an initial burst of cells in S-phase at day 2, which steadily
decreased (Fig. 4b). Notably, the behaviour of primary MECs in
3D culture is different to non-malignant human MEC lines such as
MCF-10A, which proliferate steadily over a period of 7–10 days
before exiting cell cycle [29].
The culture of primary MECs in 3D BM-matrix mimics some of
the conditions the cells are exposed to in vivo, with the presence of
basement membrane proteins and a 3D structure. We hypothe-
sised that, despite this loss in proliferation whilst culturing in 3D,
the intrinsic potential to undergo cell cycle may not be lost in those
conditions. We therefore tested whether the proliferation potential
of primary MECs could be maintained in 3D culture over a period
of several days, such that when acini were isolated and replated
onto 2D ECM, the cells efficiently enter S-phase again.
Mammary acini were isolated from the 3D BM-matrix in sterile
PBS containing 5 mM EDTA, which retained the acinar structure
of the MECs but removed the BM-matrix, and then transferred to
pre-coated collagen I culture dishes (Fig. 4c). The cells migrated
out of the 3D structure, proliferated and formed a monolayer on
the 2D collagen (Fig. 4d).
When MECs were cultured as 3D acini for 2 days and then
replated into 2D, the number of cells in S-phase peaked 2 days
later, similar to primary MECs (Fig. 4ei). Interestingly, these cells
maintained a high level of cell cycle (i.e. more than 20%) for a
longer time period than cells plated onto a 2D substratum directly
after tissue isolation (compare Fig. 4ei with Fig 1a). The duration
of 3D culture before replating the cells did not affect the ability to
MECs to proliferate when entering 2D culture (Fig. 4eii, iii). For
example, even after culture in 3D for 7-days when proliferation
was reduced to 2%, the cells showed a significant and dramatic cell
cycle burst when replated into 2D cultures (Fig. 4eiii). Indeed,
regardless of the time that the primary MECs were cultured in 3D,
the cells showed an increase in proliferation after transfer to 2D
conditions, such that ,30% of the cells were in cycle 2 days after
replating. Interestingly, for cells that had been in 3D culture for
longer, the 2D proliferation kinetics and amplitude returned to the
normal 2D profile (compare Fig. 4eiii with Fig. 1a).
Removing MECs from their in vivo environment to standard
2D culture conditions disables their ability to proliferate beyond
a few days. However mimicking in vivo conditions using 3D
BM-matrix, maintained the proliferative potential of the MECs
for at least 7 days, so that after replating into 2D culture, a
significantly higher proportion of cells were able to enter cell
cycle again.
3D culture maintains, but does not reset the ability for
MECs to proliferate
Cells in 2D culture lost the ability to proliferate after 3–4 days,
and replating the cells in 2D could not restore this. In contrast,
cells initially cultured in 3D retained the ability to proliferate when
they were replated in 2D. We therefore determined whether
replating 2D cultures into 3D BM-matrix could reset the ability of
MECs to proliferate at the levels seen immediately after isolating
cells from tissue, or whether it purely maintained the proliferation
potential of the cells at the point that they were put into 3D BM-
matrix.
Primary MECs were cultured for a varying amount of time in
2D on collagen, then replated in 3D BM-Matrix. After 48 h, the
MECs were isolated from 3D BM-matrix using PBS/EDTA and
replated back onto 2D collagen for a further 4 days. The
proliferation was analysed by EdU over the course of the
experiment (Fig. 5).
When the cells were transferred to 3D BM-matrix at the peak of
their proliferation in 2D (i.e. day 2), and then re-cultured in 2D,
the cells were able to attain a proliferation rate of 13%. This was
maintained for 2 days and declined thereafter (Fig. 5a). In contrast,
when the cells had lost their ability to progress through S-phase
after 3–5 days in 2D, then transferred to 3D BM-matrix for 2 days
before being replated back onto 2D collagen, the proliferation
level was much lower with less than 10% of the cells being EdU
positive (Fig. 5b and c).
These results show that 3D BM-matrix maintains the cells’
proliferation potential at the point when they were placed into 3D
BM-matrix. For cells that had lost their ability to proliferate in 2D
culture, it did not reset the cells to the state they were in when they
were isolated from the mammary gland. Thus, the cellular
microenvironment has a dramatic effect on determining the
intrinsic ability of the MECs to permanently exit cell cycle.
Plating cells in 3D culture allows for effective gene
deletion using the CreER system
One strategy to understand proliferative mechanisms is to delete
the genes or deplete expression of genes encoding cell cycle
regulators. While plasmid transfection is a standard methodology
in established cell lines, this is not possible in primary MECs,
where ,0.5% cells can be transfected by any means that we have
tried (unpublished data). Primary cell cultures with limited
lifespans require more sophisticated techniques, such as the use
of Cre-mediated gene deletion of floxed-alleles. However, because
proteins frequently require several days to be turned over
following ablation of the genes that encode them, the window of
opportunity for doing this in MECs while maintaining proliferative
potential is extremely limited. The ability of MECs to retain their
proliferative potential in 3D culture over 7 days, by manipulating
their environment, provides an opportunity to delete genes and
their encoded proteins before replating the cells in 2D culture in
order to analyse the resulting phenotype.
As proof of principle that this approach works, we tested if
MECs in which the b1-integrin gene had been excised in 3D
culture, showed integrin protein loss and cell cycle defects after
Figure 2. Proliferation is not enhanced or extended by mammary gland growth factors or different ECM proteins. (a) MECs were
treated with (i) FGF, (ii) RANKL, and (iii) Wnt3a at the time of plating for the duration of culturing, and the proliferation was determined each day over
6-d. In each case, statistical analysis in control and growth factor treated MECs was compared by ANOVA. The pairs of samples were found to be not
significantly different (ns). At each time point, the difference in %EdU-positive cells was compared to that at day-2 (i.e. the maximum), and found to
be significant, p,0.001 (not shown on the graphs). (b) MECs were plated on dishes coated with collagen I, laminin, vitronectin, fibronectin, or on
plastic, and proliferation was determined 4-d after plating. The difference in %EdU-positive cells between collagen and the other substrata was:
plastic p,0.001; vitronectin p,0.01; laminin and fibronectin p,0.1 (not shown on graph).
doi:10.1371/journal.pone.0018144.g002
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sequence similar to that shown in Fig. 4ii). MECs from Itgb1
fx/fx;
CreER
TM mice were cultured in 3D BM-Matrix in the presence or
absence of 4-hydroxytamixofen (4OHT) for 3 days, then replated
onto 2D ECM in normal medium. 2 days later, the 4OHT-treated
cells showed complete b1-integrin removal and a corresponding
reduction in cell cycle, while the control cells proliferated strongly
(Fig 6). This methodology now provides a robust strategy for
examining the mechanisms behind integrin-mediated control of
cell cycle, which we have followed up [30].
Discussion
We have discovered that manipulating ECM dimensionality can
alter the lifespan of primary luminal MECs in culture. These cells
almost completely lose their ability to undergo cell cycle in
conventional monolayer culture after 3 days, and this can be
overcome by replating the cells in 3D, but not by growth factors.
Thus, it is possible to increase the life span of the MECs by
culturing them in a 3D matrix before plating in a 2D surface. This
indicates that there is a dominance of cellular microenvironment
over growth factors for controlling epithelial cell cycle. However,
3D culture is not able to reset proliferative potential when cells
have already lost this capacity after 2D culture. The extended
window of proliferation afforded by 3D culture, prior to plating
cells in monolayer, provides an operational advantage for genetic
manipulation of primary cultures of non-immortalised MECs,
because it permits sufficient time for gene deletion, e.g. using Cre-
mediated recombination or mRNA depletion with shRNA, to
enable mechanistic studies on cell cycle regulation.
Limitations in primary MEC proliferation in 2D culture
Variousstrategies to culture luminal MECs from both mouse and
human have been used in order to study mechanisms of growth
regulation and cancer progression in breast. However, the normal
culture environment has a profoundly negative effect on the ability
of MECs to proliferate [23,31]. Luminal MECs have a limited
lifespan in vitro, and previous studies noted that mouse MEC
proliferation in the first passage reduced to less than 10% [32].
We have examined the proliferation profile of primary luminal
MECs in 2D monolayer culture over a 6 day period. The most
effective ECM substratum was collagen I, and soluble factors
included serum, EGF, insulin and hydrocortisone [23,33]. The
cells showed a burst of proliferation during the first 2–3 days of
culture, which subsequently dropped to an almost undetectable
level. The low level of proliferation could not be rescued by
addition of growth factors that are now known to have a key role
in mammary gland development in vivo, such as RANKL, FGF-2,
and Wnt3a, or by replating the cells to release the contact
inhibition. Indeed, we did not identify any conventional
procedures that could be used to promote luminal MEC growth
in primary culture or after passage, which is a similar finding to
that of previous investigators.
Strategies to increase MEC proliferation
Overcoming senescence and identifying conditions that pro-
mote continuous cellular proliferation are basic requirements for
cells to grow ex vivo. Mouse luminal MEC lines have been
established that retain the ability to differentiate and form ducts
after in vivo transplantation, but this is extremely rare, and cell
passage usually results in cessation of growth or acquisition of
tumorigenic characteristics [34]. In some cases, culturing cells in
collagen gels for several weeks before plating in 2D has been
successful, but the majority of these lines are genetically altered
because they form hyperplasias in vivo [14]. The generation of
MEC lines can be assisted by cellular immortalisation techniques
such as expression of SV40 large T antigen or TERT [35,36], or
by providing conditions in which rare variants with increased
proliferation potential can emerge [13]. However, immortalisation
often disrupts cell cycle regulatory mechanisms, or results in
epigenetic or genomic changes that allow cells to escape
quiescence [7]. It is therefore not an ideal state from which to
study the proliferation mechanisms of normal cells [8].
There is an intimate relationship between luminal MECs and
other cell types within the mammary gland. For example, stromal-
epithelial interactions regulate epithelial growth, survival, migra-
tion and differentiation [37,38]. Co-culturing primary MECs with
other cell types can recreate the normal organisation of breast
lobules [39,40]. Moreover, lethally irradiated cells of the immortal
LA7 rat mammary tumour line [19], fibroblasts [41] or the
mammary fat pad [42] have been used to increase the growth of
MECs. This however is not experimentally practicable when
mechanisms of MEC behaviour are studied in isolation, or when
suitable markers are not available to distinguish between the cell
types allowing the unambiguous identification of the epithelial cells
within the culture model [43]. Stromal cells do not contact luminal
cells directly in vivo because they are separated from them by
basement membrane, and in some cases the effect they have on
epithelial cell behaviour has been attributed to the production of
ECM proteins [44]. We therefore tested whether providing MECs
with basement membrane proteins in the form of 3D-matrix might
modulate the proliferative potential of MECs.
Manipulating the 3D culture environment changes MEC
proliferative characteristics
The culture microenvironment has a vast effect on cellular
morphology and function. For example, it is well established that
alveolar luminal MECs grown in monolayer cannot differentiate,
whereas the equivalent cells cultured in 3D BM-matrix express
tissue-specific genes [9]. This is because of a complex requirement
for integrin-laminin interactions to license the prolactin/Stat5
pathway [45].
We have now shown that culturing alveolar luminal MECs for
up to 7 days in 3D BM-matrix allows the proliferation of bulk cell
cultures to be studied in subsequent 2D culture over a longer
timeframe than when cells are initially plated in monolayer.
Interestingly, the kinetics of proliferation in 3D culture are similar
to those in 2D culture, with MECs showing an initial increase of
cell cycle 2–3 days after plating, followed by a decline. Thus 3D
culture per se does not alter proliferation response. However, the
cells have a remarkable plasticity in 3D culture. They can be
maintained for at least one week under those conditions and when
they are replated into 2D culture they show a substantial burst of
Figure 3. MEC proliferation is largely ablated by replating. (a) MECs were cultured on collagen I for (i) 2-d or (ii) 4-d before trypsinising and
replating onto fresh collagen I coated plates, and proliferation was then assessed daily for 4-d. Note that in each of these graphs in Fig. 3, the % of
proliferating cells was very low, i.e. ,6%, and we did not note significant differences between the values (not shown on graph). (b) Cells replated 2-d
after isolation were plated onto different ECM proteins and proliferation determined 24-h after replating. (c) Replated cells were treated with FGF,
RANKL or Wnt3a in various combinations, and proliferation was determined 1-d or 2-d after replating. (d) Proliferation of replated cells originally
isolated from either day 10–12 or day 16–18 pregnant mice was compared.
doi:10.1371/journal.pone.0018144.g003
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culture for up to a week in 2D culture results in permanent
cessation of growth. This is not quiescence because the cells cannot
be stimulated to enter the cell cycle again, and the cells do not
express senescence markers. Rather, they eventually become
apoptotic because they do not have the correct ECM survival
signals [11,46].
Although the virgin luminal MECs have similar growth kinetics
to alveolar cells in 2D culture, interestingly these cells continue to
proliferate slowly over several weeks in 3D culture to form ducts
(Cheung and Streuli, unpublished). It may be that our results using
3D cultures in this paper reflect the use of alveolar cells, which
have a limited proliferation potential in vivo. The expansion of the
alveolar cells in pregnancy is dramatic, however it ceases once the
gland has become filled with cells at around the start of lactation,
and the natural subsequent response is for the cells to undergo
apoptosis during weaning.
Together, our results show that 2D culture conditions are not
suitable for extended growth of primary mouse MECs, whether
they are isolated from virgin or pregnant animals. In contrast, 3D
culture provides a microenvironment in which the cells maintain
their proliferative potential. Alveolar cells exit cell cycle as they
form acini, but if they are removed from this environment, they
can proliferate again for a window of time, reflecting the plasticity
of MECs.
A strategy to study cell cycle mechanisms in primary cell
culture
The limited proliferation potential of primary MECs causes
significant technical problems for dissecting the molecular basis of
cell cycle control in these cells. New strategies for elucidating gene
function include the use of Cre-Lox gene deletion and silencing
with shRNAs. However, both of these techniques rely on a
sufficient time being available for the endogenous gene products to
be turned over by the targeted cell. In some cases, deleting or
depleting long-lived gene products involved in cell cycle regulation
may not be compatible with the 2–3 days available for maximum
S-phase potential in primary MECs. For example, cell adhesion
plays an important role in regulating proliferation, yet many cell
adhesion proteins have long half-lives.
Our new method for extending the proliferation window of
MECs now provides opportunities for dissecting how the cell cycle
is controlled in normal non-immortalised epithelia [30]. For
example, it affords sufficient time for genes to be deleted using the
Cre-LoxP system, as illustrated in Fig 6. In that case, a floxed gene
was deleted by 4OHT-activation of Cre recombinase, thereby
enabling the consequences of gene deletion to be studied after
replating the cells. The example presented pertains to the beta1-
inetgrin gene, but the method would be suitable for primary
MECs from any mouse harbouring flox alleles in combination
with transgenic CreER
TM.
In addition, this method of replating cells to maintain cells for
prolonged periods is also valuable for other types of genetic
modification. An increasingly used technique for primary cell
cultures is the use of lentiviral-mediated gene transfer. We have
now established this methodology for gene silencing with
shRNAmiRs and for gene overexpression using lentivirus
constructs. For example, by exploiting the replating time schedule
shown in Fig 5a, we have found that we can achieve high
efficiency lentiviral gene transfer by infecting cells in 2D, then
transferring the cells to 3D culture conditions for direct analysis, or
for subsequent replating in order to study the consequences of
gene modification in 2D cultures (Wu and Streuli, unpublished).
Both of these methods now provide tractable means of genetic
analysis in primary MEC culture, which up to now have been
hampered by extremely low efficiencies of transfection and
retroviral gene transfer.
Materials and Methods
Animals
Mice were housed and maintained according to the University
of Manchester and UK Home Office guidelines for animal
research. Animals were bred under Home Office Project Licence
40/3155, and approved by the University of Manchester ethical
review process. Experiments were conducted according to S1
killing of the Animals Scientific Procedures Act 1986.
Primary mouse mammary epithelial cell culture
MECs were isolated and cultured from ICR mice as described
[11]. All studies in this paper used primary MEC cultures. In some
studies, we used cells from the Itgb1
fx/fx;CreER
TM mouse line,
which was derived by crossing the Itgb1
fx/fx and CreER
TM mouse
lines [47,48]. All cells were from pregnant mice (pregnancy days
P16–18), unless otherwise stated.
The cultures dishes were prepared as follows; Rat tail collagen I
was diluted in cold PBS to give a final concentration of 10 mg/ml
and dishes were coated with 100 ml per cm
2 dish area, resulting in
a coating density of 10 mg/cm
2. The extracellular matrix proteins
laminin (12 mg/ml) fibronectin (12 mg/ml) and vitronectin (3 mg/
ml) were purchased from Sigma UK. The proteins were diluted to
the specified concentrations in cold PBS. The ECM protein/PBS
mixture was incubated overnight at 4uC or 1–2 hours at 37uC.
The dishes were washed three times with cold PBS. Engelbreth-
Holm-Swarm mouse sarcoma basement membrane matrix (3D
BM-matrix) was purchased from BD Biosciences. 3D BM-matrix
was defrosted on ice and spread over the culture plates using the
end of a blue tip before incubating at 37uC for 30 min to set. Both
2D ECM proteins and 3D BM-matrix coated plates were
conditioned with the serum/fetuin mix, containing double the
concentration of growth factors and antibiotics, for approximately
3–4 hours at 37uC before plating the cells.
Cells were cultured in complete growth media containing 5 mg/
ml insulin, 1 mg/ml hydrocortisone (Sigma), 3 ng/ml epidermal
growth factor (EGF),10% foetal calf serum (Biowest), 50 U/ml
penicillin/streptomycin, 0.25 mg/ml fungizone and 50 mg/ml
gentamycin in Ham’s F12 medium (Gibco). All cultures were
maintained at 37uC in a 5% CO2 atmosphere. Cre-mediated
Figure 4. 3D culture maintains the potential of MECs to proliferate when they are subsequently returned to conventional 2D
culture. (a) MECs were plated directly onto 3D BM-matrix, treated with EdU each day, and confocal projection images were obtained. (b) The
percentage of EdU positive nuclei was determined in comparison to the total number of DAPI-staining cells, each day over 6-d. (c) 3D acini were
isolated after 2-d culture in 3D BM-matrix by washing in PBS-EDTA to dissolve the matrix followed by centrifugation to recover the acini, which were
replated onto 2D collagen I. (d) The cells proliferated and emigrated from the acini. Proliferation in the 2D cultures was determined by EdU
incorporation each day after replating. (e) Proliferation was determined each day in 3D culture and then in the resulting 2D cultures. Cells were
cultured in 3D for (i) 2-d, (ii) 3-d, or (iii) 7-d before the acini were isolated and replated onto 2D collagen I. Statistical significance determined by
ANOVA is indicated: ***=p,0.001. Here we have only included the statistical differences in the %EdU positive cells between the last day of culture in
3D and the first 2 days of culture on 2D.
doi:10.1371/journal.pone.0018144.g004
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3-d, or (c) 5-d were replated onto 3D BM-matrix for 2-d, the acini were then isolated using PBS-EDTA and subsequently replated back onto 2D
collagen-coated dishes. Proliferation was assessed each day. Statistical differences (ANOVA) in the %EdU positive cells between the last day of culture
in 3D and the first day of culture on 2D are indicated.
doi:10.1371/journal.pone.0018144.g005
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fx/fx;
CreER
TM MECs with 100 nM 4OHT.
Isolation of mammary gland acini from 3D BM-matrix
using PBS-EDTA
MECs cultured on 3D BM-matrix were incubated in sterile
PBS/5 mM EDTA, scraped off the dish using a cell scraper or end
of a blue tip, transferred to Falcon tubes, and incubated on ice for
5 min with gentle shaking [49]. This, together with wash from
dishes, was transferred to a fresh Falcon tube and centrifuged
(426g, 3 min). Resulting acini were resuspended in fresh PBS-
EDTA, incubated on ice for 5 min, recentrifuged, washed in fresh
media, and resuspended in the final volume of complete media
and plated onto collagen I-coated dishes. Most acini adhered to
the substrata within a few hours, and the cells migrated as sheets of
cells onto the dishes.
Immunofluorescence staining in 2D and 3D
MECs were fixed in 4% paraformaldehyde/PBS (10 min, RT),
and permeabilised in 0.2% Triton X100/PBS (5 min, RT). The
blocking reagent was 5% goat serum (Biosera), Primary antibodies
that recognise cytokeratin 5 (AF138) (Covance), and alpha-tubulin
(T-9026) (Sigma), and secondary anti-rabbit Alexa 594 and anti-
mouse Alexa 488 antibodies (Invitrogen). Nuclei were stained with
Hoechst 33342 (1:10000 in PBS) for 2–3 min. The coverslips were
mounted onto twin frosted glass slides using ProLongH Gold
antifade reagent (Invitrogen). The cells were visualised using a
Zeiss Axioplan2 microscope equipped with a Hamamatsu ORCA-
ER digital camera and images were captured and processed using
OpenLab software (Improvision UK).
2D and 3D EdU proliferation assay
MECs were pulsed with 10 mM EdU, added to current culture
media, for 8 hours to measure DNA synthesis [50]. The cells were
fixed in 4% paraformaldehyde, permeabilised using 0.5% Triton
X100, and blocked 10% goat serum in PBS. EdU was detected by
incubating cells with fresh Click-iT
TM buffer for approximately
30 min, protected from light (Click-iT
TM EdU Alexa FluorH 488
Imaging Kit # C10083 from Invitrogen). The cells were washed
once using the wash solution provided and a normal immunoflu-
orescence protocol was used to co-stain for other proteins,
protecting from light at all times. The cells were counted blind
and the number of EdU labelled nuclei calculated as a percentage
of the total DAPI stained nuclei. An average of 2000 cells was
counted per experiment for a minimum of 3 independent
experiments.
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